Complete enrollment of Phase 2 SunStone trial in systemic lupus erythematosus
Delivered after the deadline (133 days after the deadline)
AI-assessed · human review in progress Found and assessed by AI from the cited sources. Shown with its evidence; it is not counted in any Kept Score until confirmed.
- Announced
- 5 Feb 2025
- Due
- 31 Dec 2025
- Delivered
- 13 May 2026
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“Complete enrollment in 2025 in the Phase 2 SunStone trial in patients with SLE”
What we found
Evidence strength A What the grades mean
Zenas BioPharma announced completion of SunStone trial enrollment in its May 13, 2026 Q1 2026 report, missing the original 2025 year-end deadline.
-
A Zenas BioPharma Announces Key 2024 Accomplishments and 2025 Business Objectives Original commitment: complete SunStone enrollment in 2025
-
D Zenas BioPharma Reports First Quarter 2026 Financial Results and Provides Corporate Update First announcement that SunStone trial enrollment was completed
-
D Zenas BioPharma Reports Fourth Quarter and Full Year 2025 Financial Results As of year-end 2025, SunStone trial still described as 'ongoing', not enrollment-complete
Checked 17 Sep 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical milestone
- Indicative materiality
- Medium rules
- Action
- Complete
How this entry was checked
- Commitment recordedRecorded from the company's filing.
- First checkAn AI model read the company's later filings and recorded the outcome with a quoted passage.
- Second check: disagreesGemini (Google) re-read the evidence blind and read it as “no_evidence”.
- Tie-breakA stronger model read the evidence and both earlier answers, without knowing which was recorded, and agrees with the second check.
Not yet confirmed. Shown on the record, but it will not count in any score until it is confirmed. How verification works
Are you Zenas BioPharma, Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2025-ZBIO-000205 · Corrections policy